• Login
    Search 
    •   MMUST Institutional Repository
    • Search
    •   MMUST Institutional Repository
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-8 of 8

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Polymorphisms in the Fc Gamma Receptor IIIA and Toll-Like Receptor 9 Are Associated with Protection against Severe Malarial Anemia and Changes in Circulating Gamma Interferon Levels 

    Munde, Elly O.; Okeyo, Winnie A.; Anyona, Samwel B.; Raballah, Evans; Konah, Stephen; Okumu, Wilson; Ogonda, Lilian; Vulule, John; Ouma, Collins (ASM Journals, 2012-11-12)
    An understanding of the immunogenetic basis of naturally acquired immunity to Plasmodium falciparum infection would aid in the designing of a rationally based malaria vaccine. Variants within the Fc gamma receptors (FcγRs) ...
    Thumbnail

    Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels 

    Okeyo, Winnie A; Munde, Elly O; Okumu, Wilson; Raballah, Evans; Anyona, Samuel B; Vulule, John M; Ong’echa, John M; Perkins, Douglas J; Ouma, Collins (BMC Immunology, 2013-03-25)
    In holoendemic Plasmodium falciparum transmission areas such as western Kenya, severe malarial anemia [SMA, hemoglobin (Hb) < 6.0 g/dL, with any density parasitemia] is the most common clinical manifestation of severe ...
    Thumbnail

    Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya 

    Onyango, Elizabeth O; Ayodo, George; Watsierah, Carren A; Were, Tom; Okumu, Wilson; Anyona, Samuel B; Raballah, Evans; Okoth, John M; Gumo, Sussy; Orinda, George O; Ouma, Collins (National Library of Medicine, 2012-06-24)
    Background: Over the years, reports implicate improper anti-malarial use as a major contributor of morbidity and mortality amongst millions of residents in malaria endemic areas, Kenya included. However, there are limited ...
    Thumbnail

    Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels 

    Okeyo, Winnie A; Munde, Elly O; Okumu, Wilson; Raballah, Evans; Anyona, Samuel B; Vulule, John M; Ong’echa, John M; Perkins, Douglas J; Ouma, Collins (BMC Imunology, 2013-03-25)
    n holoendemic Plasmodium falciparum transmission areas such as western Kenya, severe malarial anemia [SMA, hemoglobin (Hb) < 6.0 g/dL, with any density parasitemia] is the most common clinical manifestation of severe malaria ...
    Thumbnail

    Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya 

    Onyango, Elizabeth O; Ayodo, George; Watsierah, Carren A; Were, Tom; Okumu, Wilson; Anyona, Samuel B; Raballah, Evans; Okoth, John M; Gumo, Sussy; Orinda, George O; Ouma, Collins (National Library of Medicine, 2012-06-24)
    Background: Over the years, reports implicate improper anti-malarial use as a major contributor of morbidity and mortality amongst millions of residents in malaria endemic areas, Kenya included. However, there are limited ...
    Thumbnail

    Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels. 

    Okeyo, Winnie A; Munde, Elly O; Okumu, Wilson; Raballah, Evans; Anyona, Samuel B; Vulule, John M; Ong’echa, John M; Perkins, Douglas J; Ouma, Collins (BMC Immunology, 2013-03-13)
    In holoendemic Plasmodium falciparum transmission areas such as western Kenya, severe malarial anemia [SMA, hemoglobin (Hb) < 6.0 g/dL, with any density parasitemia] is the most common clinical manifestation of severe ...
    Thumbnail

    The role of mycobacterium tuberculosis antigen specific cytokines in determination of acid fast bacilli culture status in pulmonary tuberculosis patients co-infected with human immunodeficiency virus 

    Kisuya, Job; Chemtai, Alex; Raballah, Evans; Okumu, Wilson; Keter, Alfred; Ouma, Collins (The Pan African Medical Journal, 2018-11-08)
    Introduction: the interaction between Mycobacterium tuberculosis and HIV leads to rapid progression of tuberculosis (TB) and human immunodeficiency virus (HIV)-induced immunosuppression. Diagnosis of TB in these patients ...
    Thumbnail

    Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya 

    Onyango, Elizabeth O; Ayodo, George; Watsierah, Carren A; Were, Tom; Okumu, Wilson; Anyona, Samuel B; Raballah, Evans; Okoth, John M; Gumo, Sussy; Orinda, George O; Ouma, Collins (National Library of Medicine, 2012-06-24)
    Background: Over the years, reports implicate improper anti-malarial use as a major contributor of morbidity and mortality amongst millions of residents in malaria endemic areas, Kenya included. However, there are limited ...

    MMUST Library copyright © 2011-2022  MMUST Open Access Policy
    Contact Us | Send Feedback
     

     

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Discover

    Author
    Okumu, Wilson (8)
    Ouma, Collins (8)
    Raballah, Evans (8)
    Anyona, Samuel B (6)Ayodo, George (3)Gumo, Sussy (3)Munde, Elly O (3)Okeyo, Winnie A (3)Okoth, John M (3)Ong’echa, John M (3)... View MoreSubjectInterleukin (IL)-13, promoter polymorphisms, (-7402 T/G,-4729G/A) ,condition, susceptibility , pediatric, severe, malarial ,anemia , circulating ,IL-13 levels. (1)Interleukin (IL)-13, promoter, polymorphisms, (-7402 T/G ,4729G/A) ,condition, susceptibility, pediatric, severe, malarial, anemia,circulating, IL-13, levels (1)Interleukin (IL)-13, promoter, polymorphisms, (-7402 T/G and -4729G/A) ,condition, susceptibility, pediatric ,severe, malarial, anemia , circulating IL-13 levels. (1)non-adherence, Artemisinin-based combination therapy, malaria, population (1)non-adherence, Artemisinin-based,combination therapy, malaria, population (1)non-adherence, Artemisinin-based,combination therapy, malaria, population, (1)Polymorphisms , Fc Gamma, Receptor IIIA, Toll-Like Receptor 9 , Associated , Protection, against Severe, Malarial, Anemia , Changes , Circulating, Gamma, Interferon, Levels (1)Role, mycobacterium, tuberculosis, antigen, specific, cytokines, determination ,acid,fast, bacilli, culture, status, pulmonary, tuberculosis, patients, co-infected, human, immunodeficiency, virus (1)... View MoreDate Issued2012 (4)2013 (3)2018 (1)Has File(s)Yes (8)

    MMUST Library copyright © 2011-2022  MMUST Open Access Policy
    Contact Us | Send Feedback